Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Search content at Albert Einstein College of Medicine
Home
Faculty
Departments
Grants
Publications
Prizes
Induction Therapy: When and How
Evan Joye
,
Shivank Madan
, Snehal R. Patel
Medicine
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Induction Therapy: When and How'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Activated T Cells
25%
Alemtuzumab
25%
Antibody Induction
25%
Antithymocyte Globulin
25%
Basiliximab
50%
CD25
25%
CD52 Antigen
25%
Contemporary Practice
25%
Daclizumab
25%
Drug Use
25%
Early Postoperative Period
25%
Graft Acceptance
25%
Graft Rejection
25%
IL2RA
25%
Immunosuppression
50%
Induction Therapy
100%
Infection-related
25%
Interleukin-2
25%
Life-threatening Infections
25%
Lymphocytes
25%
Maintenance Immunosuppression
25%
Monocytes
25%
Natural Killer Cells
25%
Patient Outcomes
25%
Rat Monoclonal Antibodies
25%
Solid Organ Transplant
25%
Specific Antibodies
25%
T Cells
50%
Therapy Drugs
25%
Thymocytes
25%
Immunology and Microbiology
Alemtuzumab
33%
Anti-Thymocyte Globulin
33%
Basiliximab
66%
CD25
33%
CD52 Antigen
33%
Daclizumab
33%
Drug Therapy
33%
Immunosuppression
100%
Infection
33%
Infectious Disease
33%
Interleukin 2
33%
Lymphocyte
33%
Monoclonal Antibody
33%
Monocyte
33%
Natural Killer Cell
33%
Rat
33%
T Cell
100%
Thymocyte
33%